| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 912.25B | 928.83B | 896.67B | 875.17B | 811.58B |
| Gross Profit | 485.41B | 473.92B | 457.40B | 420.77B | 405.49B |
| EBITDA | 201.01B | 186.83B | 188.41B | 155.33B | 168.51B |
| Net Income | 89.27B | 82.55B | 90.16B | 87.81B | 96.72B |
Balance Sheet | |||||
| Total Assets | 1.57T | 1.53T | 1.41T | 1.13T | 983.84B |
| Cash, Cash Equivalents and Short-Term Investments | 145.01B | 136.00B | 137.94B | 131.93B | 130.44B |
| Total Debt | 160.00B | 437.05B | 365.11B | 146.60B | 92.73B |
| Total Liabilities | 582.71B | 623.68B | 570.58B | 315.67B | 251.02B |
| Stockholders Equity | 988.56B | 905.73B | 840.70B | 818.10B | 732.81B |
Cash Flow | |||||
| Free Cash Flow | 107.50B | 22.95B | 57.11B | -22.54B | -15.96B |
| Operating Cash Flow | 148.91B | 144.38B | 181.16B | 91.40B | 85.56B |
| Investing Cash Flow | -55.10B | -127.86B | -133.11B | -132.54B | -119.98B |
| Financing Cash Flow | -86.50B | 1.29B | -55.38B | 36.90B | 17.73B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | ¥614.51B | 18.39 | 31.11% | ― | 13.25% | 104.75% | |
63 Neutral | ¥1.49T | 16.37 | 9.29% | 1.11% | ― | ― | |
62 Neutral | ¥91.85B | 7.90 | 6.96% | 2.98% | 3.43% | 31.33% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥563.34B | 31.07 | 4.18% | 2.57% | 3.85% | -43.62% | |
54 Neutral | ¥118.29B | 14.76 | ― | 2.08% | 7.92% | -20.32% | |
46 Neutral | ¥1.61T | -13.21 | -21.14% | ― | 10.70% | 36.82% |